Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb 1:9:30.
doi: 10.3389/fphar.2018.00030. eCollection 2018.

Recent Advances in CNS P2X7 Physiology and Pharmacology: Focus on Neuropsychiatric Disorders

Anindya Bhattacharya  1
Affiliations
Review

Recent Advances in CNS P2X7 Physiology and Pharmacology: Focus on Neuropsychiatric Disorders

Anindya Bhattacharya. Front Pharmacol. .

Abstract

The ATP-gated P2X7 ion channel is an abundant microglial protein in the CNS that plays an important pathological role in executing ATP-driven danger signal transduction. Emerging data has generated scientific interest and excitement around targeting the P2X7 ion channel as a potential drug target for CNS disorders. Over the past years, a wealth of data has been published on CNS P2X7 biology, in particular the role of P2X7 in microglial cells, and in vivo effects of brain-penetrant P2X7 antagonists. Likewise, significant progress has been made around the medicinal chemistry of CNS P2X7 ligands, as antagonists for in vivo target validation in models of CNS diseases, to identification of two clinical compounds (JNJ-54175446 and JNJ-55308942) and finally, discovery of P2X7 PET ligands. This review is an attempt to bring together the current understanding of P2X7 in the CNS with a focus on P2X7 as a drug target in neuropsychiatric disorders.

Keywords: IL-1beta; P2X7; bipolar disorder; depression; microglia; neuroinflammation; neuropsychiatry; schizophrenia.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
P2X7 antagonists that transitioned into clinical development.
FIGURE 2
FIGURE 2
Brain-penetrant P2X7 antagonists.
FIGURE 3
FIGURE 3
P2X7 PET ligands.
See this image and copyright information in PMC

References

    1. Abdi M. H., Beswick P. J., Billinton A., Chambers L. J., Charlton A., Collins S. D., et al. (2010). Discovery and structure–activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor. Bioorg. Med. Chem. Lett. 20 5080–5084. 10.1016/j.bmcl.2010.07.033 - DOI - PubMed
    1. Ali Z., Laurijssens B., Ostenfeld T., McHugh S., Stylianou A., Scott-Stevens P., et al. (2013). Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects. Br. J. Clin. Pharmacol. 75 197–207. 10.1111/j.1365-2125.2012.04320.x - DOI - PMC - PubMed
    1. Backlund L., Lavebratt C., Frisen L., Nikamo P., Hukic Sudic D., Traskman-Bendz L., et al. (2012). P2RX7: expression responds to sleep deprivation and associates with rapid cycling in bipolar disorder type 1. PLOS ONE 7:e43057. 10.1371/journal.pone.0043057 - DOI - PMC - PubMed
    1. Backlund L., Nikamo P., Hukic D. S., Ek I. R., Traskman-Bendz L., Landen M., et al. (2011). Cognitive manic symptoms associated with the P2RX7 gene in bipolar disorder. Bipolar Disord. 13 500–508. 10.1111/j.1399-5618.2011.00952.x - DOI - PubMed
    1. Barden N., Harvey M., Gagne B., Shink E., Tremblay M., Raymond C., et al. (2006). Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder. Am. J. Med. Genet B Neuropsychiatr. Genet. 141B 374–382. - PubMed

LinkOut - more resources